J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. Dr_ProeveHe takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity’s core product RBM – EarlyBird.


“We welcome Dr. Proeve and believe, as a team, we can bring the RBM concept to new frontiers, make it absolutely essential for patient safety, clinical trials transparency and improved data quality.” (A. Andrianov)